CAS 1639417-53-0

Tenalisib

CAS: 1639417-53-0

Tenalisib (RP6530) (RP6530) is a potent and selective inhibitor of PI3Kδ and PI3Kγ(IC50 values of 25 and 33 nM, respectively.)

Formula: C₂₃H₁₈FN₅O₂

Purity: 99.71%

Color and Shape: Solid

Molecular weight: 415.42

Ref: TM-T13119

Tenalisib

CAS: 1639417-53-0

Formula: C₂₃H₁₈FN₅O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 415.4197

Ref: IN-DA01EN4F

Tenalisib

CAS: 1639417-53-0

Tenalisib

Formula: C₂₃H₁₈FN₅O₂

Purity: ≥98%

Molecular weight: 415.42

Ref: 54-BUP04682

Tenalisib

CAS: 1639417-53-0

(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one

Formula: C₂₃H₁₈FN₅O₂

Purity: 98%

Molecular weight: 415.42

Ref: IN-DG318420

Tenalisib

CAS: 1639417-53-0

Purity: 98%

Molecular weight: 415.428009

Ref: 10-F866867

Tenalisib (RP6530)

CAS: 1639417-53-0

Tenalisib is a protein inhibitor that blocks the protein kinase activity of the m2 phenotype. It has been shown to be clinically effective in treating primary T-cell lymphomas, skin cancer, and cancers of the hematopoietic system. Tenalisib inhibits the growth of cancer cells by blocking the transcriptional regulation of genes that promote cell proliferation and survival. Tenalisib is also a chemotherapeutic treatment for human macrophages and hematopoietic cells. The drug has also shown anti-tumor effects in mice with skin cancer as well as antitumor effects on human myeloid-derived suppressor cells. Tenalisib is metabolized by cytochrome P450 enzymes, which are found in high concentrations in hepatic tissue.

Formula: C₂₃H₁₈FN₅O₂

Purity: Min. 95%

Molecular weight: 415.42 g/mol

Ref: 3D-PQC41753